Document:

Careview Communications, Inc. 8-K 

Exhibit 10.53

 

TENTH
AMENDMENT TO

NOTE AND WARRANT PURCHASE AGREEMENT

This TENTH AMENDMENT
TO NOTE AND WARRANT PURCHASE AGREEMENT, dated as of July 13, 2018 (this “Amendment”), is made by and among
CAREVIEW COMMUNICATIONS, INC., a Nevada corporation (the “Company”), the HealthCor Parties and the Investors
(each as defined below), as holders of a majority of the shares of Common Stock issued or issuable (on an as converted basis) upon
conversion of the Notes and Warrants (collectively, the “Majority Investors”), and such of the Existing Investors
(as defined below) who are identified as investors on Annex I attached hereto (the “Investors”).

WITNESSETH:

WHEREAS,
the Company, HealthCor Partners Fund, L.P. (“HealthCor Partners”), HealthCor Hybrid Offshore Master Fund, L.P.
(“HealthCor Hybrid” and, together with HealthCor Partners, the “HealthCor Parties”) and certain
additional investors that purchased additional Notes and additional Warrants on February 17, 2015 (the “2015 Investors”)
and on February 23, 2018 (the “February 2018 Investors” and, together with the 2015 Investors and the HealthCor
Parties, the “Existing Investors”) are parties to that certain Note and Warrant Purchase Agreement, dated as
of April 21, 2011 (as amended from time to time, including without limitation pursuant to that certain Note and Warrant Amendment
Agreement dated December 30, 2011, that certain Second Amendment to Note and Warrant Purchase Agreement dated January 31, 2012,
that certain Third Amendment to Note and Warrant Purchase Agreement dated August 20, 2013, that certain Fourth Amendment to Note
and Warrant Purchase Agreement dated January 16, 2014, that certain Fifth Amendment to Note and Warrant Purchase Agreement dated
December 15, 2014, that certain Sixth Amendment to Note and Warrant Purchase Agreement dated March 31, 2015, that certain Seventh
Amendment to Note and Warrant Purchase Agreement dated June 26, 2015, that certain Eighth Amendment to Note and Warrant Purchase
Agreement dated February 23, 2018 and that certain Ninth Amendment to Note and Warrant Purchase Agreement dated July 10, 2018,
the “Purchase Agreement”);

WHEREAS, as
contemplated by the Purchase Agreement, the Company issued and sold (a) $20,000,000 initial principal amount of Notes (the
“2011 Notes”) and Warrants to purchase 11,782,859 shares of Common Stock (the “2011 Warrants”)
to the HealthCor Parties on April 21, 2011, (b) $5,000,000 initial principal amount of Supplemental Closing Notes (the
“2012 Notes”) to the HealthCor Parties on January 31, 2012, (c) $5,000,000 initial principal amount of
2014 Supplemental Closing Notes and 2014 Supplemental Warrants to purchase 4,000,000 shares of Common Stock to the HealthCor Parties
on January 16, 2014, (d) $6,000,000 initial principal amount of Fifth Amendment Supplemental Closing Notes and Fifth Amendment
Supplemental Warrants to purchase 3,692,308 shares of Common Stock to HealthCor Partners and the 2015 Investors on February 17,
2015 and (e) $2,050,000 initial principal amount of Eighth Amendment Supplemental Notes and Eighth Amendment Supplemental
Warrants to purchase 512,500 shares of Common Stock to the February 2018 Investors on February 23, 2018;

WHEREAS,
pursuant to Section 7.9 of the Purchase Agreement and subject to the terms and conditions contained herein, the parties hereto
desire to amend the Purchase Agreement as set forth herein for the purposes of, among other things, providing for an additional
investment in the Company by the Investors;

    	 	1	 

    	 

    

 

WHEREAS,
the Investors wish to purchase from the Company, and the Company wishes to sell and issue to the Investors, upon the terms and
conditions stated herein and in the Purchase Agreement, additional Notes in the initial aggregate principal amount of $1,000,000,
with a conversion price per share equal to $0.05 (subject to adjustment as described therein) (the “Tenth Amendment Supplemental
Closing Notes”) on the later of July 13, 2018 or the satisfaction of the closing conditions outlined herein (the
“Tenth Amendment Supplemental Closing Date”); and

WHEREAS,
the Company and the Investors are executing and delivering this Amendment in reliance upon the exemption from securities registration
afforded by the provisions of Regulation D, as promulgated by the Commission under the Act.

NOW, THEREFORE,
in consideration of the mutual promises, representations, warranties and covenants contained herein and in the Purchase Agreement,
which represent integral components of the transactions contemplated hereby and thereby and shall be fully enforceable by the parties
hereto, and for other good and valuable consideration, the receipt and sufficiency of which hereby acknowledged, the Company, the
Majority Investors and the Investors mutually agree as follows:

1.                 
Definitions. Capitalized terms used in this Amendment but not defined in this Amendment shall have the meanings ascribed
to them in the Purchase Agreement.

2.                 
Amendment to Purchase Agreement. Section 1.3 of the Purchase Agreement is hereby amended and restated in its entirety
to read as follows:

“Sale of Additional
Securities. After the Closing, the Company may sell to the Investors, on the same terms and conditions as those contained in
this Agreement (as amended from time to time), up to $19,050,000 in additional Notes and Warrants to purchase an additional 8,204,808
shares of Common Stock, and (a) any such additional Notes shall be included within the definition of “Notes” under
this Agreement; (b) any such additional Warrants shall be included within the definition of “Warrants” under this Agreement;
(c) any such additional Notes and additional Warrants shall be included within the definition of “Closing Securities”
under this Agreement; (d) any shares of Common Stock issuable upon conversion of any such additional Notes shall be included within
the definition of “Note Shares” under this Agreement; (e) any shares of Common Stock issuable upon the exercise of
any such additional Warrants shall be included within the definition of “Warrant Shares” under this Agreement; and
(f) any amendment or joinder to this Agreement, the Notes, the Warrants, the Security Agreement, the IP Security Agreement, the
Registration Rights Agreement, the PDL Subordination Agreement, the PDL Credit Agreement or any other documents contemplated or
necessitated hereby in order to further consummate the sale of any such additional Notes and/or additional Warrants shall be included
within the definition of “Transaction Documents” under this Agreement. Any such additional Notes shall be substantially
in the form of the senior secured convertible note attached hereto as Exhibit A, with such updates to the “Issuance
Date”, “Maturity Date”, “First Five Year Note Period”, “Conversion Price” and other terms
as shall be mutually acceptable to the Company and the Investors. Any such additional Warrants shall be substantially in the form
of common stock warrant attached hereto attached hereto as Exhibit B, with such updates to the “Expiration Date”,
“Warrant Price” and other terms as shall be mutually acceptable to the Company and the Investors.”

    	 	2	 

    	 

    

3.                 
Issuance of Tenth Amendment Supplemental Closing Notes. Subject to the terms and conditions of this Amendment and
the Purchase Agreement, on the Tenth Amendment Supplemental Closing Date, each of the Investors listed on Annex I shall
severally, and not jointly, purchase from the Company, and the Company shall sell and issue to each Investor, the Tenth Amendment
Supplemental Closing Notes in the respective amounts set forth opposite each such Investor’s name on Annex I in exchange
for a cash payment by each such Investor of the amount set forth opposite such Investor’s name on Annex I (the “Tenth
Amendment Supplemental Purchase Price”). The Tenth Amendment Supplemental Closing Notes shall be substantially in the
form attached hereto as Exhibit A-1. The closing of the purchase, sale and issuance of the Tenth Amendment Supplemental
Closing Notes (the “Tenth Amendment Supplemental Closing”) shall take place on the Tenth Amendment Supplemental
Closing Date at the offices of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo PC, One Financial Center, Boston, MA 02111, or at
such other location as the Company and the Investors shall mutually agree. At the Tenth Amendment Supplemental Closing, the Company
shall have satisfied the closing conditions set forth in subsections (c)-(h), (k) and (l) of Section 4.1 of the Purchase Agreement
as of the Tenth Amendment Supplemental Closing Date (for avoidance of doubt, reading references to the “Closing Date”
in such subsections to refer to the Tenth Amendment Supplemental Closing Date) and shall deliver to the Investors the Tenth Amendment
Supplemental Closing Notes, each registered in such name or names as the Investors may designate. On the Tenth Amendment Supplemental
Closing Date, the Investors shall deliver their respective portion of the Tenth Amendment Supplemental Purchase Price to the Company,
payable by wire transfer in same day funds to an account specified by the Company in writing. The Tenth Amendment Supplemental
Closing Notes shall be secured as and to the same extent as the other Notes issued pursuant to the Purchase Agreement, as described
in the Transaction Documents, including, without limitation, the Security Agreement and IP Security Agreement.

4.                 
Condition Precedent. The Tenth Amendment Supplemental Closing shall be further conditioned upon the execution and
delivery, as of the Tenth Amendment Supplemental Closing, by the Company, CareView Texas and PDL of the Third Amendment to Credit
Agreement, in the form attached as Exhibit B hereto.

5.                 
Bringdown of Company’s Representations and Warranties. The Company represents and warrants to the Investors
that, except as set forth in a disclosure letter delivered to the Investors as of the Tenth Amendment Supplemental Closing Date,
the statements contained in Article 2 and the first sentence of Section 5.1(k) of the Purchase Agreement are
true and correct as of the Tenth Amendment Supplemental Closing Date as though made as of such date, except to the extent such
representations and warranties are specifically made as of a particular date (in which case such representations and warranties
are true and correct as of such other specified date). For the avoidance of doubt, as a result of the operation of this Section 5
and for purposes hereof, any representation and warranty made in the Purchase Agreement “as of the Closing Date” shall
be deemed to be made as of the Tenth Amendment Supplemental Closing Date, any reference in a representation and warranty to “the
date hereof” shall be deemed to refer to the date of this Amendment, any retroactive time period set forth in a representation
and warranty shall be deemed to be retroactive from the date of this Amendment for such time period, and any reference to “Closing
Securities” shall be deemed to refer to the Tenth Amendment Supplemental Closing Notes.

    	 	3	 

    	 

    

6.                 
Bringdown of Investors’ Representations and Warranties. Each Investor, severally and not jointly, represents
and warrants to the Company that the statements contained in Article 3 of the Purchase Agreement are true and correct
as of the Tenth Amendment Supplemental Closing Date as though made as of the Tenth Amendment Supplemental Closing Date (for this
purpose, reading any reference to “Closing Securities” in such Article 3 to refer only to the Tenth Amendment
Supplemental Closing Notes).

7.                 
Form D and Blue Sky. The Company agrees to file a Form D with respect to the Tenth Amendment Supplemental
Closing Notes as required under Regulation D and to provide a copy thereof to the Investors promptly after such filing. The
Company shall take such action as is necessary in order to obtain an exemption for or to qualify the Tenth Amendment Supplemental
Closing Notes for sale to the Investors at the Tenth Amendment Supplemental Closing pursuant to this Amendment under applicable
securities or “Blue Sky” laws of the states of the United States, and shall provide evidence of any such exemption
or qualification so taken to the Investors on or prior to the Tenth Amendment Supplemental Closing Date promptly upon the request
of any Investor.

8.                 
Acknowledgement and Undertaking by Company. The Company agrees and acknowledges that the transactions described in
this Amendment and the issuance of the Tenth Amendment Supplemental Closing Notes and shares of Common Stock upon exercise or conversion
of the Tenth Amendment Supplemental Closing Notes are intended to be exempt from Section 16(b) of the Exchange Act to the maximum
extent permitted by law including pursuant to Rule 16b-3 under the Exchange Act and the Commission’s releases and interpretations,
and will, or will cause its successors and assigns to, from time to time as and when requested by the Investors, execute and deliver,
or cause to be executed and delivered, to the extent it may lawfully do so, all such documents and instruments and take, or cause
to be taken, to the extent it may lawfully do so, all such further actions as the Investors may reasonably deem necessary and desirable
to facilitate and effect any such exemption. 

9.                 
No Further Amendments. Except as amended by this Amendment, the Purchase Agreement shall remain in full force and
effect in accordance with its terms.

    	 	4	 

    	 

    

10.             
Miscellaneous.

(a)              
Ratification and Confirmation. The Company acknowledges, agrees and confirms that: (x) the Purchase Agreement and
each of the other Transaction Documents, as amended and otherwise modified by the amendments and other modifications specifically
provided herein or contemplated hereby, are and shall continue to be in full force and effect and are hereby in all respects ratified
and confirmed; and (y) without limiting the generality of the foregoing clause (x), (i) all obligations, liabilities and Indebtedness
of the Company under the Transaction Documents, as amended hereby, constitute “Obligations” (as defined in the Security
Agreement) secured by and entitled to the benefits of the security set forth in the Security Agreement and the IP Security Agreement,
and the liens and security interests granted in favor of the Investors under the terms of the Security Agreement and the IP Security
Agreement are and remain perfected, effective, enforceable and valid and such liens and security interests are, in each case, a
first priority lien and security interest (except to the extent otherwise expressly permitted by the Transaction Documents) and
such liens and security interests are hereby in all respects ratified and confirmed, and (ii) the shares of Common Stock issuable
upon exercise or conversion of the Tenth Supplemental Closing Notes shall constitute “Registrable Securities” under
the Registration Rights Agreement.

(b)              
Expenses. The Company will pay and bear full responsibility for the reasonable legal fees and other out-of-pocket
costs and expenses of the Investors attributable to the negotiation and consummation of the transactions contemplated hereby.

(c)              
Further Assurances. The Company shall duly execute and deliver, or cause to be duly executed and delivered, at its
own cost and expense, such further instruments and documents and to take all such action, in each case as may be necessary or proper
in the reasonable judgment of the Investors to carry out the provisions and purposes of this Amendment.

(d)              
Survival. The representations, warranties, covenants and agreements made herein shall survive any investigation made
by any party hereto, the execution and delivery of this Amendment and the closing of the transactions contemplated hereby.

(e)              
Governing Law. All questions concerning the construction, interpretation and validity of this Amendment shall be
governed by and construed and enforced in accordance with the domestic laws of the State of Delaware without giving effect to any
choice or conflict of law provision or rule (whether in the State of Delaware or any other jurisdiction) that would cause the application
of the laws of any jurisdiction other than the State of Delaware. In furtherance of the foregoing, the internal law of the State
of Delaware will control the interpretation and construction of this Amendment, even if under such jurisdiction’s choice
of law or conflict of law analysis, the substantive law of some other jurisdiction would ordinarily or necessarily apply.

(f)               
Construction. The Company and the Investors acknowledge that the Company and its independent counsel and the Investors
and their independent counsel have jointly reviewed and drafted this document, and agree that any rule of construction and interpretation
to the effect that drafting ambiguities are to be resolved against the drafting party shall not be employed.

    	 	5	 

    	 

    

(g)              
Counterparts; Facsimile and Electronic Signatures. This Amendment may be executed in any number of counterparts,
and each such counterpart hereof shall be deemed to be an original instrument, but all such counterparts together shall constitute
but one agreement. Counterpart signatures to this Amendment delivered by facsimile or other electronic transmission shall be acceptable
and binding.

(h)              
Headings. The section and paragraph headings contained in this Amendment are for reference purposes only and shall
not affect in any way the meaning or interpretation of this Amendment.

[Signature Pages Follow]

    	 	6	 

    	 

    

IN WITNESS WHEREOF,
each of the undersigned has duly executed this Tenth Amendment to Note and Warrant Purchase Agreement as of the date first written
above.

 

	 	COMPANY:
	 	 	 
	 	CareView Communications, Inc., a Nevada corporation
	 	 	 
	 	By:	/s/ Steven G. Johnson
	 	 	Name: Steven G. Johnson
	 	 	Title: President

 

 

[Signature Page to Tenth Amendment to Note and Warrant Purchase Agreement]

    	 

    	 

    

 

 

	 	MAJORITY INVESTORS:
	 	 	 
	 	HealthCor Partners Fund, L.P.
	 	By: HealthCor Partners Management L.P., as Manager
	 	By: HealthCor Partners Management, G.P., LLC, as General Partner
	 	 	 
	 	By:	/s/ Jeffrey C. Lightcap
	 	Name: Jeffrey C. Lightcap
	 	Title: Senior Managing Director
	 	Address:	HealthCor Partners
	 	 	1325 Avenue of Americas, 27th Floor
	 	 	New York, NY 10019
	 	 	 
	 	 
	 	HealthCor Hybrid Offshore Master Fund, L.P.
	 	By: HealthCor Hybrid Offshore G.P., LLC, as General Partner
	 	 	 
	 	By:	/s/ Joseph P. Healey
	 	Name: Joseph P. Healey
	 	Title: Trustee
	 	Address:	HealthCor Partners
	 	 	1325 Avenue of Americas, 27th Floor
	 	 	New York, NY 10019
	 	 
	 	 
	 	 	 	 

 

[Signature Page to Tenth Amendment to Note and Warrant Purchase Agreement]

    	 

    	 

    

 

	 	
        MAJORITY INVESTORS 

        AND INVESTORS:

	 	 
	 	 
	 	/s/ Steven B. Epstein
	 	Steven B. Epstein
	 	 
	 	 
	 	/s/ Dr. James R. Higgins
	 	Dr. James R. Higgins
	 	 
	 	 
	 	/s/ Steven G. Johnson
	 	Steven G. Johnson
	 	 
	 	 
	 	/s/ Jeffrey C. Lightcap
	 	Jeffrey C. Lightcap
	 	 

 

 

[Signature Page to Tenth Amendment to Note and Warrant Purchase Agreement]

    	 

    	 

    

 

 

ACKNOWLEDGED AND AGREED:

 

	CareView Communications, Inc., a Texas corporation	 
	 	 	 
	By:	/s/ Steven G. Johnson	 
	Name: 	Steven G. Johnson	 
	Title: 	President	 
	 	 	 
	 	 	 
	CareView Operations, LLC	 
	 	 	 
	By:	/s/ Steven G. Johnson	 
	Name: 	Steven G. Johnson	 
	Title: 	President	 

 

 

 

[Signature Page to Tenth Amendment to Note and Warrant Purchase Agreement]

    	 

    	 

    

 

 

Annex I

 

Tenth Amendment Supplemental Closing Note
Investors

 

	Investor	Tenth Amendment

Supplemental Closing Notes	Tenth Amendment

Supplemental Warrants	Tenth Amendment

Supplemental Purchase Price
	Steven B. Epstein	$50,000	—	$50,000
	Dr. James R. Higgins	$200,000	—	$200,000
	Steven G. Johnson	$500,000	—	$500,000
	Jeffrey C. Lightcap	$250,000	—	$250,000
	TOTAL	$1,000,000	N/A	$1,000,000

 

 

    	 

    	 

    

  

Exhibit A-1

 

Form of Tenth Amendment Supplemental Closing
Notes

 

(attached)

 

 

    	 

    	 

    

 

Exhibit B

 

Form of Third Amendment to Credit Agreement

 

(attached)Careview Communications, Inc. 8-K 

Exhibit 10.54

SENIOR SECURED CONVERTIBLE NOTE

NEITHER THE ISSUANCE AND SALE OF
THIS NOTE NOR ANY SHARES OF COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF
1933, AS AMENDED (THE “SECURITIES ACT”), OR APPLICABLE STATE SECURITIES LAWS. THIS NOTE AND THE SHARES OF COMMON STOCK
ISSUABLE UPON CONVERSION OF THIS NOTE MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE
REGISTRATION STATEMENT FOR THIS NOTE OR THE SHARES OF COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE UNDER THE SECURITIES ACT,
AS APPLICABLE, OR (B) AN OPINION OF COUNSEL (SELECTED BY THE HOLDER AND REASONABLY ACCEPTABLE TO THE COMPANY), IN A FORM REASONABLY
ACCEPTABLE TO THE COMPANY, THAT THIS NOTE AND THE SHARES OF COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE MAY BE OFFERED FOR
SALE, SOLD, ASSIGNED OR TRANSFERRED PURSUANT TO AN EXEMPTION FROM REGISTRATION; PROVIDED THAT SUCH OPINION OF COUNSEL SHALL NOT
BE REQUIRED IN CONNECTION WITH ANY SUCH SALE, ASSIGNMENT OR TRANSFER TO AN INSTITUTIONAL ACCREDITED INVESTOR THAT IS, PRIOR TO
SUCH SALE, ASSIGNMENT OR TRANSFER, AN AFFILIATE OF THE HOLDER OF THIS NOTE, OR (II) UNLESS THE HOLDER PROVIDES THE COMPANY WITH
ASSURANCE (REASONABLY SATISFACTORY TO THE COMPANY) THAT SUCH NOTE OR THE SHARES OF COMMON STOCK ISSUABLE UPON THE CONVERSION OF
THE NOTE CAN BE SOLD, ASSIGNED OR TRANSFERRED PURSUANT TO RULE 144.

ANY TRANSFEREE OF THIS NOTE SHOULD
CAREFULLY REVIEW THE TERMS OF THIS NOTE, INCLUDING, WITHOUT LIMITATION, SECTIONS 3(c)(iii) AND 13(a) HEREOF. THE PRINCIPAL AMOUNT
REPRESENTED BY THIS NOTE AND, ACCORDINGLY, THE SECURITIES ISSUABLE UPON CONVERSION HEREOF MAY BE LESS THAN THE AMOUNTS SET FORTH
ON THE FACE HEREOF PURSUANT TO SECTION 3(c)(iii) OF THIS NOTE.

Notwithstanding
anything herein to the contrary, the rights and remedies granted to the Holder pursuant to this Note, the lien and security interest
granted to the Agent securing this Note and the exercise of any right or remedy by the Holder or Agent relating to this Note are
subject to the provisions of the Subordination and Intercreditor Agreement dated as of June 26, 2015 (as amended, amended and restated,
supplemented or otherwise modified from time to time in accordance with the terms thereof, the “Intercreditor Agreement”),
among PDL INVESTMENT HOLDINGS, LLC (as assignee of PDL BioPharma, Inc.) and EACH OF THE NOTE INVESTORS PARTY TO THAT CERTAIN NOTE
AND WARRANT PURCHASE AGREEMENT DATED AS OF APRIL 21, 2011, AS subsequently amended, and certain other persons party or that may
become party thereto from time to time. In the event of any conflict between the terms of the Intercreditor Agreement and this
Note, the Purchase Agreement and the other Transaction Documents (as defined in the Purchase Agreement), the terms of the Intercreditor
Agreement shall govern and control.

IN
ADDITION, THE RIGHTS AND REMEDIES GRANTED to THE HOLDER PURSUANT TO THIS NOTE, THE LIEN AND SECURITY INTEREST GRANTED TO HEALTHCOR
PARTNERS FUND, L.P., A DELAWARE LIMITED PARTNERSHIP, AS AGENT FOR THE INVESTORS UNDER THE SECURITY AGREEMENT (“AGENT”)
SECURING THIS NOTE AND THE EXERCISE OF ANY RIGHT OR REMEDY BY THE HOLDER OR AGENT RELATING TO THIS NOTE ARE further SUBJECT TO
THE PROVISIONS OF SECTIONS 3 AND 4 OF THE NINTH AMENDMENT, DATED AS OF JULY 10, 2018, TO THE PURCHASE AGREEMENT (AS DEFINED HEREIN).

 

    	 

    	 

    

 

No. F-[__]

CAREVIEW
COMMUNICATIONS, INC.

SENIOR
SECURED CONVERTIBLE NOTE

	Issuance Date:  July 13, 2018	Principal Amount:  U.S. $[__________]
	 	(subject to Section 3(c)(iii) hereof)

 

FOR VALUE RECEIVED,
CareView Communications, Inc., a Nevada corporation (the “Company”), hereby promises to pay to [______________]
or the registered assign(s) thereof (“Holder”) the principal amount set forth above (as increased and/or decreased
pursuant to the terms hereof by reason of the accrual of Interest, partial conversion or otherwise, and together with the principal
amount of any additional convertible debt instruments issued by the Company to the Holder in accordance herewith, the “Principal”)
when due, whether upon the Maturity Date, acceleration or otherwise (in each case in accordance with the terms hereof), together
with accrued interest (“Interest”) on any outstanding Principal at the First Five Year Interest Rate or the
Second Five Year Interest Rate, as applicable, from the date hereof (the “Issuance Date”) until the same becomes
due and payable, whether upon the Maturity Date, acceleration, conversion or otherwise (in each case, in accordance with the terms
hereof). This Senior Secured Convertible Note (this “Note”) is being issued pursuant to that certain Note and
Warrant Purchase Agreement, dated as of April 21, 2011, as amended by a Note and Warrant Amendment Agreement entered into as of
December 30, 2011, a Second Amendment to Note and Warrant Purchase Agreement dated as of January 31, 2012, a Third Amendment to
Note and Warrant Purchase Agreement dated as of August 20, 2013, a Fourth Amendment to Note and Warrant Purchase Agreement dated
as of January 16, 2014, a Fifth Amendment to Note and Warrant Purchase Agreement dated as of December 15, 2014, a Sixth Amendment
to Note and Warrant Purchase Agreement dated as of March 31, 2015, a Seventh Amendment to Note and Warrant Purchase Agreement dated
as of June 26, 2015, an Eighth Amendment to Note and Warrant Purchase Agreement dated as of February 23, 2018, a Ninth Amendment
to Note and Warrant Purchase Agreement dated as of July 10, 2018 and a Tenth Amendment to Note and Warrant Purchase Agreement dated
as of July 13, 2018 by and among the Company, the Holder and the other Investors named therein (the “Purchase Agreement”),
and is entitled to the benefits of, and evidences obligations incurred under, the Purchase Agreement and the other Transaction
Documents (as defined in the Purchase Agreement), to which reference is made for a description of the security for this Note and
for a statement of the terms and conditions on which the Company is permitted and required to make prepayments and repayments of
principal of the obligations evidenced hereby and on which such obligations may be declared to be immediately due and payable.
This Note represents a full recourse obligation of the Company.

Certain capitalized
terms used herein are defined in Section 23.

(1)              
MATURITY. On the Maturity Date, the Holder shall surrender this Note to the Company and the Company shall pay to
the Holder an amount in cash representing all outstanding Principal, accrued and unpaid Interest and accrued and unpaid Late Charges
(as defined in Section 19(b)), if any. The “Maturity Date” shall be July 12, 2028.

    	 	1	 

    	 

    

 

(2)              
INTEREST; INTEREST RATE.

(a)              
So long as no Event of Default has occurred and is continuing, the outstanding Principal balance of this Note shall accrue
Interest from the Issuance Date through July 12, 2023 (the “First Five Year Note Period”), at the rate of twelve
and one-half percent (12.5%) per annum (based on a 360-day year and the actual number of days elapsed in
any partial year) (the “First Five Year Interest Rate”), compounding quarterly, which
accrued Interest shall be added to the outstanding Principal balance of this Note on the last day of each
calendar quarter and shall thereafter itself, as part of such Principal balance, accrue Interest at the First Five Year Interest
Rate (and, during the Second Five Year Note Period (as defined below), at the Second Five Year Interest Rate (as defined below)),
compounding quarterly. All such accrued Interest added to the outstanding Principal balance pursuant to the immediately preceding
sentence shall be payable on the same terms and subject to
the same conditions set forth herein. Upon the occurrence of an Event of Default, Interest shall be calculated at the Default Rate
as set forth in Section 2(c) below.

(b)              
So long as no Event of Default has occurred and is continuing, the outstanding Principal balance of this Note shall accrue
Interest from and after the end of the First Five Year Note Period through the Maturity Date (the “Second Five Year Note
Period”), at the rate of ten percent (10%) per annum (based on a 360-day year and the actual number of days elapsed in
any partial year) (the “Second Five Year Interest Rate”). The Interest accruing during the Second Five Year
Note Period may be paid quarterly in arrears in cash or, at the Company’s option, such Interest may be added to the outstanding
Principal balance of the Note on the last day of each calendar quarter and shall thereafter itself, as part of such Principal balance,
accrue Interest at the Second Five Year Interest Rate, compounding quarterly. All such accrued Interest added to the outstanding
Principal balance pursuant to the immediately preceding sentence shall be payable on the same terms and subject to the same conditions
set forth herein. Upon the occurrence of an Event of Default, Interest shall be calculated at the Default Rate as set forth in
Section 2(c) below.

(c)              
From and after the date such Event of Default occurred, the First Five Year Interest Rate or the Second Five Year Interest
Rate, whichever is then applicable, shall be increased by five percent (5%) and otherwise applied consistently with the provisions
of Sections 2(a) and 2(b) (the “Default Rate”).

    	 	2	 

    	 

    

 

(d)              
 

(i)                
In addition to the foregoing, if any Major Event occurs at any time during the First Five Year Note Period, then all amounts
of Interest that are then scheduled to be paid or accrued pursuant to Section 2(a) through and including the last day of the First
Five Year Note Period, but that have not yet been paid pursuant to Section 2(a) (such amount, the “First Five Year Major
Event Interest Amount”), will accelerate and become immediately due and payable by the Company by the issuance to the
Holder of an additional convertible debt instrument with the same terms as this Note, in a principal amount equal to the First
Five Year Major Event Interest Amount, and, at any time from and after the occurrence of the Major Event, the Holder may, at its
option, elect to (A) convert this Note and such convertible debt instrument at the then effective Conversion Rate or (B) redeem
all or any portion of the outstanding Principal balance of this Note and such convertible debt instrument, provided that for so
long as this Note or such convertible debt instrument remain outstanding, subject to Section 2(d)(ii) below, no additional Interest
shall accrue on this Note or such additional convertible debt instrument until the commencement of the Second Five Year Note Period.
If any Major Event occurs at any time during the Second Five Year Note Period, then all amounts of Interest that are then scheduled
to be paid or accrued pursuant to Section 2(b) through and including the last day of the Second Five Year Note Period (assuming
for this purpose that the Company would elect to pay all such Interest in cash), but that have not yet been paid pursuant to Section
2(b) (such amount, the “Second Five Year Major Event Interest Amount”), will accelerate and become immediately
due and payable by the Company by the issuance to the Holder of an additional convertible debt instrument with the same terms as
this Note and in a principal amount equal to the Second Five Year Major Event Interest Amount or, at the Company’s option,
by cash payment in immediately available funds of an amount equal to the Second Five Year Major Event Interest Amount paid within
five (5) Business Days of the occurrence of the Major Event. At any time following the occurrence of the Major Event, the Holder
may, at its option, elect to (X) convert this Note and such convertible debt instrument (if any) at the then effective Conversion
Rate or (Y) redeem all or any portion of the outstanding Principal balance of this Note and such convertible debt instrument (if
any), provided that, for so long as this Note or any such convertible debt instrument remain outstanding, subject to Section 2(d)(ii)
below, no additional Interest shall accrue on this Note or such additional convertible debt instrument for the duration of the
Second Five Year Note Period. For purposes of this Note, the term “Major Event” shall mean the occurrence of
(i) the signing of a definitive agreement or a series of agreements for the transfer, sale, lease or license of all or substantially
all of the Company’s assets or capital securities; (ii) the signing of a definitive agreement to consolidate or merge with
or into another Person (whether or not the Company is the Successor Entity) that results or would result, after giving effect to
the consummation of the transactions contemplated by such agreement, in such other Person (or the holders of such other Person’s
capital stock immediately prior to the transaction) (other than the Holder or its Affiliates) being or becoming the beneficial
owner (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of thirty-five percent (35%) or more of any class of
the Company’s or the Successor Entity’s outstanding capital securities; (iii) the signing of a definitive agreement
or a series of agreements to consummate a stock acquisition or sale or other business combination (including, without limitation,
a reorganization, recapitalization, or spin-off), or series thereof, with any other Person or Persons (other than the Holder or
its Affiliates) that results or would result, after giving effect to the consummation of the transactions contemplated by such
agreement or agreements, in such other Person or Persons being or becoming the beneficial owner (within the meaning of Rule 13d-3
promulgated under the Exchange Act) of thirty-five percent (35%) or more of any class of the Company’s outstanding capital
securities; (iv) the commencement or other public announcement by any Person (other than the Company, the Holder or the Holder’s
Affiliates) of a purchase, tender or exchange offer for 35% or more of the outstanding shares of Common Stock (not including any
shares of Common Stock held by the Person or Persons making or party to, or associated or affiliated with the Persons making or
party to, such purchase, tender or exchange offer), (v) any “person” or “group” (as these terms are used
for purposes of Sections 13(d) and 14(d) of the Exchange Act) (other than the Holder or its Affiliates) is or shall
become the “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of either
(x) 35% or more of the aggregate ordinary voting power represented by issued and outstanding Common Stock or (y) 35%
or more of the aggregate ordinary voting power represented by issued and outstanding Common Stock not held by such Person or Persons
as of the date hereof or (vi) the public announcement by any Person, Persons or group (other than the Company, the Holder or the
Holder’s Affiliates) of a bona fide intention to enter into any of the agreements or to engage in or commence any
of the actions described in clauses (i) through (v) above, or otherwise reflecting an intent to acquire the Company or all or substantially
all of its assets or capital securities, or the public announcement by the Company of its receipt of a communication from such
a Person, Persons or group evidencing the same.

    	 	3	 

    	 

    

(ii)             
Notwithstanding the foregoing, in the event that, following a Major Event, an Event of Default occurs during the First Five
Year Note Period while any portion of this Note and/or any convertible debt instrument issued pursuant to Section 2(d)(i) remains
outstanding (such outstanding portion, the “Post EOD Principal”), the Company shall issue to the Holder an additional
convertible debt instrument with the same terms as this Note and with a face principal amount equal to the difference (to the extent
such difference is positive) between (A) the applicable EOD Accelerated Interest (as defined in Section 4(b)) on such Post EOD
Principal, and (B) the First Five Year Major Event Interest Amount attributable to the Post EOD Principal and paid under Section
2(d)(i), and at any time following the occurrence of the Event of Default, the Holder may, at its option, elect to convert such
additional convertible debt instrument at the then effective Conversion Rate or redeem all or any portion of the outstanding Principal
balance of such convertible debt instrument. In the event that, following a Major Event, an Event of Default occurs during the
Second Five Year Note Period while any Post EOD Principal remains outstanding, the Company shall issue to the Holder an additional
convertible debt instrument with the same terms as this Note and with a face principal amount equal to the difference (to the extent
such difference is positive) between (X) the applicable EOD Accelerated Interest attributable to such Post EOD Principal and (Y)
the Second Five Year Major Event Interest Amount attributable to the Post EOD Principal and paid under Section 2(d)(i), and at
any time following the occurrence of the Event of Default, the Holder may, at its option, elect to convert such additional convertible
debt instrument at the then effective Conversion Rate or redeem all or any portion of the outstanding Principal balance of such
convertible debt instrument, provided, however, that the Company shall also have the option of paying the foregoing amount in cash
upon the occurrence of such Event of Default during the Second Five Year Note Period.

(e)              
Notwithstanding any other provision of this Note, the aggregate annual interest rate payable with respect to this Note (including
all charges and fees deemed to be interest pursuant to applicable law) shall not exceed the maximum annual rate permitted by applicable
law. In the event the aggregate annual interest rate payable with respect to this Note (including all charges and fees deemed to
be interest under applicable laws) exceeds the maximum legal rate, the Company shall only pay Interest to the Holder at the maximum
permitted rate and the Company shall continue to make such Interest payments at the maximum permitted rate until all amounts, fees
and obligations required to be paid hereunder have been paid in full.

    	 	4	 

    	 

    

 

(f)               
This Note is one of a series of notes issued by the Company pursuant to the Purchase Agreement. Such Notes are referred
to herein as the “Notes,” and the holders thereof (including the Holder)
are referred to herein as the “Investors.” The Notes initially issued
in calendar years 2011 and 2012 are senior in right of payment to the Notes initially issued after calendar year 2012 (including
this Note, the “Subsequent Tranche Notes”), as more fully set forth in the Purchase Agreement. The right of
an Investor to receive payments of Principal and Interest under this Note shall be pari passu with the rights of the other Investors
to receive payments of Principal and Interest under their respective Subsequent Tranche Notes, and the Company covenants that any
payments made by it with respect to the Subsequent Tranche Notes shall be made pro rata among the Investors determined
based on the ratio of the outstanding balance of Principal and Interest under each Subsequent Tranche Note divided by the aggregate
outstanding balance of Principal and Interest under all Subsequent Tranche Notes.  By the Holder’s acceptance of this
Note, the Holder agrees to the foregoing sentence.

(3)              
CONVERSION OF NOTE. This Note shall be convertible into shares of Common Stock, on the terms and conditions set forth
in this Section 3.

(a)              
Conversion Right. At any time or times on or after the Issuance Date, the Holder shall be entitled to convert any
portion of the outstanding and unpaid Conversion Amount (as defined below) into fully paid and nonassessable shares of Common Stock
in accordance with Section 3(c), at the Conversion Rate (as defined below). The Company shall not issue any fraction of a share
of Common Stock upon any conversion. If any conversion would result in the issuance of a fraction of a share of Common Stock, the
Company shall round such fraction of a share of Common Stock to the nearest whole share but shall have no obligation to pay the
Holder for any fraction of a share of Common Stock forfeited as a result of such rounding. The Company shall pay any and all stock
transfer, stamp, documentary and similar taxes (excluding any taxes on the income or gain of the Holder) that may be payable with
respect to the issuance and delivery of shares of Common Stock to the Holder upon conversion of any Conversion Amount. To the extent
permitted by law, the Company and the Holder acknowledge and agree that any conversion of all or any portion
of the Conversion Amount into shares of Common Stock pursuant to the terms of this Section 3(a) will not be treated
as a taxable transaction and the Company and the Holder agree to report any such conversion in a manner consistent
with the foregoing treatment.

(b)              
Conversion Rate. The number of shares of Common Stock issuable upon conversion of any Conversion Amount pursuant
to Section 3(a) (the “Conversion Rate”) shall be determined by dividing (x) such Conversion Amount by (y) the
Conversion Price.

(i)                
“Conversion Amount” means the sum of (A) the portion of the Principal to be converted with respect to
which this determination is being made, (B) accrued and unpaid Interest with respect to such Principal and (C) accrued and unpaid
Late Charges with respect to such Principal and Interest.

(ii)             
“Conversion Price” means $0.05, subject to adjustment as provided herein (including, without limitation,
adjustment pursuant to Section 6).

    	 	5	 

    	 

    

 

(c)              
Mechanics of Conversion.

(i)                
Optional Conversion. To convert any Conversion Amount into shares of Common Stock on any date (a “Conversion
Date”), the Holder shall (A) transmit by facsimile (or otherwise deliver), for receipt on or prior to 4:00 p.m., Dallas,
TX time, on such date, a copy of an executed notice of conversion in the form attached hereto as Exhibit I (the “Conversion
Notice”) to the Company and (B) if required by Section 3(c)(iii), cause this Note to be delivered to the Company as soon
as practicable on or following such date. On or before 4:00 p.m., Dallas, TX time, on the first (1st) Business Day following
the date of receipt of a Conversion Notice, the Company shall transmit by facsimile a confirmation of receipt of such Conversion
Notice to the Holder (at the facsimile number provided in the Conversion Notice) and the Company’s transfer agent, if any
(the “Transfer Agent”). On or before 4:00 p.m., Dallas, TX time, on the third (3rd) Business Day
following the date of receipt of a Conversion Notice (the “Share Delivery Date”), the Company shall (X) provided
the Transfer Agent is participating in the DTC Fast Automated Securities Transfer Program, cause the Transfer Agent to credit such
aggregate number of shares of Common Stock to which the Holder shall be entitled to the Holder’s or its designee’s
balance account with DTC through its Deposit/Withdrawal At Custodian (“DWAC”) system, or (Y) if the Transfer
Agent is not participating in the DTC Fast Automated Securities Transfer Program, or if the Holder otherwise requests, issue and
deliver to the address as specified in the Conversion Notice, a certificate, registered in the name of the Holder or its designee,
for the number of shares of Common Stock to which the Holder shall be entitled. If this Note is physically surrendered for conversion
as required by Section 3(c)(iii) and the outstanding Principal of this Note is greater than the Principal portion of the Conversion
Amount being converted, then the Company shall as soon as practicable and in no event later than three (3) Business Days after
receipt of this Note and at its own expense, issue and deliver to the Holder a new Note (in accordance with Section 13(d)), representing
the outstanding Principal not converted. The Person or Persons entitled to receive the shares of Common Stock issuable upon a conversion
of this Note shall be treated for all purposes as the record holder or holders of such shares of Common Stock on the Conversion
Date.

(ii)             
Company’s Failure to Timely Convert. If, at any time, the Company shall fail to credit the Holder’s balance
account with DTC or issue a certificate to the Holder, as the case may be, upon conversion of any Conversion Amount on or prior
to the date which is seven (7) Business Days after the Conversion Date (a “Conversion Failure”), then (A) the
Company shall pay damages to the Holder for each day of such Conversion Failure in an amount equal to 1.5% of the product of (I)
the sum of the number of shares of Common Stock not issued to the Holder on or prior to the Share Delivery Date and to which the
Holder is entitled, and (II) the Closing Sale Price of the Common Stock on the Share Delivery Date and (B) the Holder, upon written
notice to the Company, may void its Conversion Notice with respect to, and retain or have returned, as the case may be, any portion
of this Note that has not been converted pursuant to such Conversion Notice; provided that the voiding of a Conversion Notice
shall not affect the Company’s obligations to make any payments which have accrued prior to the date of such notice pursuant
to this Section 3(c)(ii) or otherwise.

    	 	6	 

    	 

    

 

(iii)           
Book-Entry. Notwithstanding anything to the contrary set forth herein, upon conversion of any portion of this Note
in accordance with the terms hereof, the Holder shall not be required to physically surrender this Note to the Company unless (A)
the full Conversion Amount represented by this Note is being converted or (B) the Holder has provided the Company with prior
written notice (which notice may be included in a Conversion Notice) requesting physical surrender and reissue of this Note. The
Holder and the Company shall maintain records showing the Principal, Interest and Late Charges converted and the dates of such
conversions or shall use such other method, reasonably satisfactory to the Holder and the Company, so as not to require physical
surrender of this Note upon conversion.

(iv)            
Disputes. In the event of a dispute between the Company and the Holder of this Note as to the number of shares of
Common Stock issuable to the Holder in connection with a conversion of this Note, the Company shall issue to the Holder the number
of shares of Common Stock not in dispute and resolve such dispute in accordance with Section 18.

(4)              
RIGHTS UPON EVENT OF DEFAULT.

(a)              
Event of Default. Each of the following events shall constitute an “Event of Default”:

(i)                
the Company’s failure to pay to the Investors any amount of Principal when and as due under the Notes (including,
without limitation, upon a redemption request pursuant to Section 2(d));

(ii)             
the Company’s failure to pay to the Investors any amount of Interest, Late Charges or other amounts (other than the
amounts specified in clause (i)) when and as due under the Notes if such failure continues for a period of at least three (3) Business
Days;

(iii)           
any acceleration prior to maturity of any Indebtedness referred to in clause (a) or (b) of the definition thereof of the
Company or any of its Subsidiaries consisting of principal individually or in the aggregate equal to or greater than $500,000;

(iv)            
the Company or any of its Subsidiaries, pursuant to or within the meaning of Title 11, U.S. Code, or any similar Federal,
foreign or state law for the relief of debtors (collectively, “Bankruptcy Law”), (A) commences a voluntary case,
(B) consents to the entry of an order for relief against it in an involuntary case, (C) consents to the appointment of a receiver,
trustee, assignee, liquidator or similar official (a “Custodian”), (D) makes a general assignment for the benefit
of its creditors or (E) admits in writing that it is generally unable to pay its debts as they become due;

(v)              
a court of competent jurisdiction enters an order or decree under any Bankruptcy Law that is not vacated, set aside or reversed
within sixty (60) days that (A) is for relief against the Company or any of its Subsidiaries in an involuntary case, (B) appoints
a Custodian of the Company or any of its Subsidiaries or (C) orders the liquidation of the Company or any of its Subsidiaries;

    	 	7	 

    	 

    

(vi)            
a final judgment or judgments for the payment of money aggregating in excess of $2,000,000 are rendered against the Company
or any of its Subsidiaries and which judgments are not, within sixty (60) days after the entry thereof, bonded, discharged or stayed
pending appeal, or are not discharged within sixty (60) days after the expiration of such stay; provided, however, that any judgment
which is covered by insurance or an indemnity from a credit worthy party shall not be included in calculating the $2,000,000 amount
set forth above so long as the Company provides the Holder a written statement from such insurer or indemnity provider (which written
statement shall be reasonably satisfactory to the Holder) to the effect that such judgment is covered by insurance or an indemnity
and the Company will receive the proceeds of such insurance or indemnity within sixty (60) days of the issuance of such judgment;

(vii)         
the Company or any Subsidiary breaches any negative covenant in any Transaction Document;

(viii)       
the Company breaches any affirmative covenant or agreement or materially breaches any representation or warranty in any
Transaction Document, and such breach continues for a period of at least thirty (30) days;

(ix)            
if at any time while any portion of the Notes remain outstanding (x) the Board of Directors fails to include one (1) Director
designated by the Holder(s) of at least a majority of the Principal amount of the Notes outstanding, voting as a separate class
(the “Noteholder Director”), provided that the Company shall have thirty (30) Business Days following the resignation,
removal or death or disability of the Noteholder Director to appoint a successor Noteholder Director designated by the Holder(s)
of at least a majority of the Principal amount of the Notes outstanding, voting as a separate class, unless such failure is the
result of the failure by such Holders to notify the Company of the name of the replacement Noteholder Director, in which event
the thirty (30) Business Day period shall be extended until a date which is ten (10) Business Days after notice of the name and
background of the replacement Noteholder Director is given to the Company, or (y) without the consent of the Noteholder Director
(or, in the absence of a Noteholder Director, the Holder(s) of at least a majority of the Principal amount of the Notes outstanding),
the Board of Directors exceeds seven (7) directors, or the Compensation Committee or Nominating Committee (or other committees
serving similar functions) of the Board of Directors exceeds three (3) members, or (z) the Noteholder Director is not afforded
the right to serve as a member of each of the Compensation Committee and Nominating Committee (or committees serving similar functions);

(x)              
the failure of the Company for a period of ninety (90) days following the resignation and/or departure of Steven Johnson
to engage a replacement therefor that is reasonably acceptable to Investors holding at least a majority of the Principal amount
of the Notes outstanding (the “Majority Investors”);

(xi)            
[Intentionally omitted];

(xii)         
the Company or any Subsidiary shall fail to make any payment (whether of principal, interest or otherwise and regardless
of amount) in respect of any Indebtedness in excess of $500,000 (“Material Indebtedness”), when and as the same
shall become due and payable, after giving effect to any grace period with respect thereto;

    	 	8	 

    	 

    

(xiii)       
any event or condition occurs that results in any Material Indebtedness becoming due prior to its scheduled maturity or
that enables or permits (with or without the giving of notice, the lapse of time or both) the holder or holders of any Material
Indebtedness or any trustee or agent on its or their behalf to cause such Material Indebtedness to become due, or to require the
prepayment, repurchase, redemption or defeasance thereof, prior to its scheduled maturity;

(xiv)        
there shall occur any material loss theft, damage or destruction of any Collateral (as defined in the Security Agreement)
not fully covered (subject to such reasonable deductibles as the Holder shall have approved) by insurance; or

(xv)          
either (a) the Company’s Board of Directors, a committee of the Board of Directors or the officer or officers of the
Company authorized to take such action if board action is not required, concludes that any previously issued financial statements,
including interim periods, should no longer be relied upon because of an error in such financial statements as addressed in FASB
Accounting Standards Codification Topic 250, as may be modified, supplemented or succeeded, or (b) the Company is advised by, or
receives notice from, its independent accountant that disclosure should be made or action should be taken to prevent future reliance
on a previously issued audit report or completed interim review related to previously issued financial statements, and in either
case the amended financial statements required in order to permit reliance on such financial statements for the affected periods
have not been filed with the SEC within ninety (90) days of the earliest such event; provided, however
that if the facts and/or circumstances underlying the Event of Default described in this Section 4(a)(xv) would also create
or constitute a separate Event of Default under this Note, the cure period set forth in this Section 4(a)(xv) shall not
supersede or prevent the application of any shorter cure period associated with such other applicable Event of Default, which may
be enforced separately and independently.

(b)              
Rights Upon Event of Default. Promptly after the occurrence of an Event of Default, the Company shall deliver written
notice thereof (an “Event of Default Notice”) to the Holder, and the Majority Investors may, at their option,
by notice to the Company (an “Event of Default Acceleration Notice”), declare the Default Amount to be due and
payable upon demand (an “Acceleration”), provided that upon the occurrence of an Event of Default described
in Sections 4(a)(iv) and 4(a)(v) above, such Acceleration shall occur automatically without requiring the delivery of an Event
of Default Acceleration Notice, such that the Default Amount shall automatically become immediately due and payable without any
further notice, demand or other action. For purposes hereof, the “Default Amount” shall equal the entire unpaid
Principal balance under this Note, plus all previously accrued and unpaid Interest and Late Charges, together with all future Interest
(calculated at the Default Rate pursuant to Section 2(c)) scheduled to accrue during the First Five Year Note Period (if such Acceleration
occurred during the First Five Year Note Period) or the Second Five Year Note Period (if such Acceleration occurred during the
Second Five Year Note Period) (such future Interest amount the “EOD Accelerated Interest”), in each case without
presentment, demand, protest or other notice of any kind, all of which are hereby waived by the Company. Following an Acceleration
(other than an Acceleration based on an Event of Default described in Sections 4(a)(iv) and 4(a)(v) above), the Holder shall have
the right, but not the obligation, to demand payment in full of the Default Amount at any time prior to the original Maturity Date
of this Note upon written notice to the Company (a “Demand Notice”). In the event a Demand Notice is not immediately
given upon the occurrence of an Event of Default, or the Company otherwise does not immediately pay the Default Amount when due,
interest shall continue to accrue on the Note as provided herein, provided that (i) upon an Acceleration that occurs during the
First Five Year Note Period, such Default Amount shall not accrue additional Interest until the commencement of the Second Five
Year Note Period, and (ii) upon an Acceleration that occurs during the Second Five Year Note Period, such Default Amount shall
not accrue any additional Interest for the duration of the Second Five Year Note Period. The Company shall deliver the applicable
Default Amount to the Holder (x) in the case of an Event of Default under Section 4(a)(iv) or 4(a)(v), immediately, and (y) in
the case of any other Event of Default, within five (5) Business Days after the Company’s receipt of the Demand Notice. In
the event the Company fails to deliver the Default Amount as described above, the Holder shall be permitted to exercise such rights
as a secured party or otherwise hereunder or under the other Transaction Documents to the extent permitted by applicable law.

    	 	9	 

    	 

    

(5)              
RIGHTS UPON A CHANGE OF CONTROL.

(a)              
Assumption. The Company shall not enter into or be party to a transaction resulting in a Change of Control unless
the Successor Entity assumes in writing all of the obligations of the Company under this Note and the other Transaction Documents
in accordance with the provisions of this Section 5(a) pursuant to written agreements on or prior to the consummation of such Change
of Control, including the agreement to deliver to the Holder of this Note in exchange for this Note a security of the Successor
Entity evidenced by a written instrument substantially similar in form and substance to this Note, including, without limitation,
having a principal amount and interest rate equal to the principal amounts and the interest rates of this Note (the “Successor
Note”). Upon the occurrence of any Change of Control, the Successor Entity shall succeed to, and be substituted for (so
that from and after the date of such Change of Control, the provisions of this Note referring to the “Company” shall
refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations
of the Company under this Note with the same effect as if such Successor Entity had been named as the Company herein, until such
time as the Successor Note is delivered. Upon consummation of a Reclassification or Change of Control as a result of which holders
of Common Stock shall be entitled to receive stock, securities, cash, assets or any other property with respect to or in exchange
for such Common Stock, the Company or Successor Entity, as the case may be, shall deliver to the Holder confirmation that there
shall be issued upon conversion of this Note at any time after the consummation of such Reclassification or Change of Control,
in lieu of the shares of Common Stock (or other securities, cash, assets or other property) issuable upon the conversion of this
Note prior to such Reclassification or Change of Control, such shares of stock, securities, cash, assets or any other property
whatsoever (including warrants or other purchase or subscription rights) which the Holder would have been entitled to receive upon
the happening of such Reclassification or Change of Control had this Note been converted immediately prior to such Reclassification
or Change of Control, as adjusted in accordance with the provisions of this Note. The provisions of this Section 5(a) shall apply
similarly and equally to successive Change of Control transactions and shall be applied without regard to any limitations on the
conversion of this Note.

    	 	10	 

    	 

    

(6)              
RIGHTS UPON ISSUANCE OF OTHER SECURITIES.

(a)              
Record Date. If the Company takes a record of the holders of Common Stock for the purpose of entitling them to receive
a dividend or other distribution payable in Common Stock, Options or in Convertible Securities, then such record date will be deemed
to be the date of the issue or sale of the Common Stock deemed to have been issued or sold upon the declaration of such dividend
or the making of such other distribution, as the case may be.

(b)              
Adjustment of Conversion Rate upon Subdivision or Combination of Common Stock; Stock Dividends. If the Company at
any time, or from time to time, subdivides (by any stock split, stock dividend, recapitalization or otherwise) one or more classes
of its outstanding shares of Common Stock into a greater number of shares, the Conversion Price in effect immediately prior to
such subdivision will be proportionately reduced. If the Company at any time, or from time to time, combines (by combination, reverse
stock split or otherwise) one or more classes of its outstanding shares of Common Stock into a smaller number of shares, the Conversion
Price in effect immediately prior to such combination will be proportionately increased. Any adjustment under this Section 6(b)
shall become effective at the close of business on the date the subdivision or combination becomes effective or, in the case of
a stock dividend, the date of such event.

(c)              
(i) Adjustment of Conversion Rate upon Cash Dividends and Distributions. If the Company at any time, or from time
to time, pays a dividend or makes a distribution in cash to the record holders of any class of Common Stock, then immediately after
the close of business on the day that the Common Stock trades ex-distribution, the Conversion Price then in effect shall be reduced
to an amount equal to the product of (i) the Conversion Price in effect immediately prior to such dividend or distribution and
(ii) the quotient determined by dividing (A) the Closing Sale Price of the Common Stock on the day that the Common Stock trades
ex-distribution by (B) the sum of (1) the Closing Sale Price of the Common Stock on the day that the Common Stock trades ex-distribution
plus (2) the amount per share of such dividend or distribution. The Company shall not be required to give effect to any adjustment
in the Conversion Price pursuant to this Section 6(c) unless and until the net effect of one or more adjustments (each of which
shall be carried forward until counted toward an adjustment), determined in accordance with this Section 6(c), shall have resulted
in a change of the Conversion Price by at least 1%, and when the cumulative net effect of more than one adjustment so determined
shall be to change the Conversion Price by at least 1%, such change in the Conversion Price shall then be given effect.

(ii)       Adjustment
of Conversion Rate upon Distributions of Capital Stock, Indebtedness or Other Non-Cash Assets. If the Company at any time,
or from time to time, distributes any shares of capital stock of the Company (other than Common Stock), evidences of indebtedness
or other non-cash assets (including securities of any person other than the Company but excluding (1) dividends or distributions
paid exclusively in cash or (2) dividends or distributions referred to in Section 6(b)) to the record holders of any class of Common
Stock, then the Conversion Price then in effect shall be reduced to an amount equal to the product of (A) the Conversion Price
then in effect and (B) a fraction of which the numerator shall be the Closing Sale Price per share of the Common Stock on the record
date fixed for determination of stockholders entitled to receive such distribution less the fair market value on such record date
(as determined by the Board of Directors) of the portion of the capital stock, evidences of indebtedness or other non-cash assets
so distributed applicable to one share of Common Stock (determined on the basis of the number of shares of Common Stock outstanding
on the record date) and of which the denominator shall be the Closing Sale Price per share of the Common Stock on such record date.

    	 	11	 

    	 

    

 

(d)              
[Intentionally omitted.]

(e)              
Other Events; Other Dividends and Distributions. If any event occurs of the type contemplated by the provisions of
this Section 6 but not expressly provided for by such provisions (including, without limitation, the granting of stock appreciation
rights, phantom stock rights or other rights with equity features), then the Company’s Board of Directors shall, in good
faith, make an adjustment in the Conversion Price so as to protect the rights of the Holder under this Note; provided that no such
adjustment will increase the Conversion Price as otherwise determined pursuant to this Section 6.

(f)               
Notice of Adjustment. Whenever the Conversion Price is adjusted pursuant to this Section 6, the Company shall promptly
mail notice of such adjustment to the Holder, which notice shall set forth the Conversion Price after adjustment, the date on which
such adjustment became effective and a brief statement of the facts resulting in such adjustment.

(7)              
NONCIRCUMVENTION. The Company hereby covenants and agrees that the Company will not, by amendment of its Certificate
of Incorporation, Bylaws or through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution,
issue or sale of securities, or any other voluntary action, avoid or seek to avoid the observance or performance of any of the
terms of this Note, and will at all times in good faith carry out all of the provisions of this Note and take all action as may
be required to protect the rights of the Holder of this Note.

(8)              
RESERVATION OF AUTHORIZED SHARES.

(a)              
Reservation. The Company shall at all times reserve out of its authorized and unissued shares of Common Stock a number
of shares of Common Stock equal to 100% of the Conversion Rate with respect to the full Conversion Amount of this Note, solely
for the purpose of effecting the conversion of this Note (the “Required Reserve Amount”).

(b)              
Insufficient Authorized Shares. If at any time while this Note remains outstanding the Company does not have a sufficient
number of authorized and unreserved shares of Common Stock to satisfy its obligation to reserve the Required Reserve Amount (an
“Authorized Share Failure”), then the Company shall take all action necessary to increase the Company’s
authorized shares of Common Stock to an amount sufficient to allow the Company to reserve the Required Reserve Amount. Without
limiting the generality of the foregoing sentence, as soon as practicable after the date of the occurrence of an Authorized Share
Failure, but in no event later than seventy-five (75) days after the occurrence of such Authorized Share Failure, the Company shall
hold a meeting of its stockholders for the approval of an increase in the number of authorized shares of Common Stock. In connection
with such meeting, the Company shall provide each stockholder with a proxy statement and shall use its commercially reasonable
efforts to solicit its stockholders’ approval of such increase in authorized shares of Common Stock and to cause its board
of directors to recommend to the stockholders that they approve such proposal.

    	 	12	 

    	 

    

(9)              
VOTING RIGHTS. The Holder shall have no voting rights as the Holder of this Note, except as required by law, including,
but not limited to, the General Corporation Law of the State of Nevada, and as expressly provided in this Note, the Company’s
Charter or any of the other Transaction Documents.

(10)          
OTHER COVENANTS.

(a)              
Listing. The Company shall promptly secure the listing of all of the Registrable Securities (as defined in the Registration
Rights Agreement) upon each national securities exchange and automated quotation system, if any, upon which the Common Stock is
then listed (subject to official notice of issuance) and shall maintain such listing of all Registrable Securities from time to
time issuable under the terms of the Transaction Documents. The Company shall maintain the Common Stock’s authorization for
quotation on the principal exchange or market in which it is listed. Neither the Company nor any of its Subsidiaries shall take
any action which would be reasonably expected to result in the delisting or suspension of the Common Stock on the principal market
in which it is listed, other than in connection with a transfer of listing to an Eligible Market. The Company shall pay all fees
and expenses in connection with satisfying its obligations under this Section 10(a).

(b)              
Quarterly Report of Outstanding Principal and Interest. The Company covenants to deliver to the Holder, within
30 days following the end of each calendar quarter while any portion of this Note remains outstanding, a written statement signed
by an authorized officer of the Company certifying (i) the amount of the outstanding Principal balance of this Note, including
any Interest added to Principal pursuant to Section 2(a) and 2(b) above, and (ii) all accrued but unpaid Interest on such outstanding
Principal balance, and (iii) all remaining scheduled payments of Interest through the Maturity Date, in each case as of the end
of such calendar quarter. The parties agree that the scheduled Interest payments through the Maturity Date will be calculated in
the same manner as in the Notes issued prior to the date hereof.

(c)              
Waiver of Usury Defense. The Company covenants (to the extent that it may lawfully do so) that it shall not
assert, plead (as a defense or otherwise) or in any manner whatsoever claim (and shall actively resist any attempt to compel it
to assert, plead or claim) in any action, suit or proceeding that the interest rate on this Note violates present or future usury
or other laws relating to the interest payable on any Indebtedness and shall not otherwise avail itself (and shall actively resist
any attempt to compel it to avail itself) of the benefits or advantages of any such laws.

    	 	13	 

    	 

    

(d)              
Registration Rights. The Company agrees that the Holder, as a holder of Registrable Securities (as defined in the
Registration Rights Agreement, dated as of April 21, 2011, by and among the Company and the Investors identified therein, as may
be amended and/or restated from time to time (the “Registration Rights Agreement”)), is entitled to the benefits
of the Registration Rights Agreement. Further, if (i) the Registration Statement (as defined in Registration Rights Agreement)
required by Section 2(a) of the Registration Rights Agreement, covering the Registrable Securities required to be covered thereby
is (A) not filed with the SEC on or before thirty (30) calendar days after the applicable Registration Request (as defined in Registration
Rights Agreement) (a “Filing Failure”) or (B) not declared effective by the SEC on or before the date that is
one hundred and eighty (180) calendar days after the applicable Registration Request, in each case to the extent required under
the Registration Rights Agreement (an “Effectiveness Failure”) or (ii) after the effective date of any Registration
Statement, after the second (2nd) consecutive Business Day (other than during an allowable blackout period pursuant to Section
3(g) of the Registration Rights Agreement (“Blackout Period”)) on which sales of all of the Registrable Securities
required to be included on such Registration Statement cannot be made pursuant to such Registration Statement (including, without
limitation, because of a failure to keep such Registration Statement effective, to disclose such information as is necessary for
sales to be made pursuant to such Registration Statement, or to maintain a listing of the Common Stock required for sales to be
made under the Registration Statement) (a “Maintenance Failure”), then, as relief for the damages to the Holder
by reason of any such delay in or reduction of its ability to sell the Registrable Securities, the Company shall pay to the Holder
an amount in cash equal to (A) one percent (1%) of the outstanding Principal balance of this Note on each of the following dates:
(i) the day of a Filing Failure; (ii) the day of an Effectiveness Failure; and (iii) the initial day of a Maintenance Failure,
and (B) one percent (1%) of the outstanding Principal balance of this Note on each of the following dates: (i) on every thirtieth
(30th) day after the initial day of a Filing Failure (prorated for periods totaling less than thirty (30) days) until such Filing
Failure is cured; (ii) on every thirtieth (30th) day after the initial day of an Effectiveness Failure (prorated for periods totaling
less than thirty (30) days) until such Effectiveness Failure is cured; (iii) on every thirtieth (30th) day after the initial day
of a Maintenance Failure (prorated for periods totaling less than thirty (30) days) until such Maintenance Failure is cured. The
payments to which the Holder shall be entitled pursuant to this Section 10(d) are referred to herein as “Registration
Default Payments.” Registration Default Payments shall be paid on the earlier of (I) the last day of the calendar month
during which such Registration Default Payments are incurred and (II) the third (3rd) Business Day after the event or failure giving
rise to the Registration Default Payments is cured. In the event the Company fails to make Registration Default Payments in a timely
manner, such Registration Default Payments shall bear interest at the rate of one and one-half percent (1.5%) per month (prorated
for partial months) until paid in full. If the Company has declared a Blackout Period, a Maintenance Failure shall be deemed not
to have occurred and be continuing in relation to the Registration Statement during the period specified in Section 3(g) of the
Registration Rights Agreement. Registration Default Payments shall be payable from the first day any Blackout Period exceeds the
period specified in Section 3(g) of the Registration Rights Agreement. Registration Default Payments shall cease to accrue at the
end of the Effectiveness Period (as defined in Registration Rights Agreement); provided that the foregoing shall not affect
the Company’s obligation to make Registration Default Payments for any period prior to such time. Whenever in this Note there
is mentioned, in any context, the payment of interest on, or in respect of, this Note, such mention shall be deemed to include
mention of the payment of liquidated damages on this Note to the extent that, in such context, such liquidated damages are, were
or would be payable in respect thereof pursuant to this Section 10(d). For the avoidance of doubt, the Registrable Securities required
to be included in any Registration Statement referred to in this Section 10(d) shall be determined according to the provisions
of the Registration Rights Agreement, including all references to exceptions therein in such provisions related to the “Rule
415 Amount,” as applicable.

    	 	14	 

    	 

    

(11)          
VOTE TO ISSUE, OR CHANGE THE TERMS OF, NOTE. Any provision of this Note may be amended, waived or modified only upon
the written consent of both the Company and the Majority Investors; provided, that no amendment or waiver may (a) extend
the Maturity Date of this Note, (b) decrease the Conversion Price or Conversion Rate of this Note, (c) reduce the rate or extend
the time for payment of any Interest on this Note, or (d) reduce the percentage of Notes required for consent to any modifications
of the Notes, without the consent of the Holder of this Note.

(12)          
TRANSFER. This Note and the shares of Common Stock issuable upon conversion of this Note may not be offered for sale,
sold, transferred or assigned (i) in the absence of (a) an effective registration statement for this Note or the shares of Common
Stock issuable upon conversion of this Note, as applicable, or (b) an opinion of counsel (selected by the Holder and reasonably
acceptable to the Company), in a form reasonable acceptable to the Company, that this Note and the shares of Common Stock issuable
upon conversion of this Note may be offered for sale, sold, assigned or transferred pursuant to an exemption from registration;
provided that such opinion of counsel shall not be required in connection with any such sale, assignment or transfer to
an institutional accredited investor that is, prior to such sale, assignment or transfer, an affiliate of the Holder, or (ii) unless
the Holder provides the Company with assurance (reasonably satisfactory to the Company) that such Note or the shares of Common
Stock issuable upon the conversion of this Note can be sold, assigned or transferred pursuant to Rule 144.

(13)          
REISSUANCE OF THIS NOTE.

(a)              
Transfer. This Note is issued in registered form pursuant to Treasury Regulations section 1.871-14(c)(1). The Company
(or its agent) will maintain a record of the Holder of this Note, and of Principal and Interest hereon as required by that regulation.
This Note may be transferred or otherwise assigned only by surrender of this Note and issuance of a new Note in accordance with
this Section 13, and neither this Note nor any interest herein may be sold, transferred or assigned to any Person except upon satisfaction
of the conditions specified in this Section 13. If this Note is to be transferred or assigned, the Holder shall surrender this
Note to the Company, whereupon the Company will forthwith issue and deliver upon the order of the Holder a new Note (in accordance
with Section 13(d)), registered as the Holder may request, representing the outstanding Principal being transferred by the Holder
and, if less than the entire outstanding Principal is being transferred, a new Note (in accordance with Section 13(d)) to the Holder
representing the outstanding Principal not being transferred. The Holder and any assignee, by acceptance of this Note, acknowledge
and agree that, by reason of the provisions of Section 3(c)(iii) following conversion of any portion of this Note, the outstanding
Principal represented by this Note may be less than the Principal stated on the face of this Note.

(b)              
Lost, Stolen or Mutilated Note. Upon receipt by the Company of evidence reasonably satisfactory to the Company of
the loss, theft, destruction or mutilation of this Note, and, in the case of loss, theft or destruction, of any indemnification
undertaking by the Holder to the Company in customary form and, in the case of mutilation, upon surrender and cancellation of this
Note, the Company shall execute and deliver to the Holder a new Note (in accordance with Section 13(d)) representing the then outstanding
Principal.

    	 	15	 

    	 

    

(c)              
Note Exchangeable for Different Denominations. This Note is exchangeable, upon the surrender hereof by the Holder
at the principal office of the Company, for a new Note or Notes (in accordance with Section 13(d) and in Principal amounts of at
least $100,000) representing in the aggregate the outstanding Principal of this Note, and each such new Note will represent such
portion of such outstanding Principal as is designated by the Holder at the time of such surrender.

(d)              
Issuance of New Notes. Whenever the Company is required to issue a new Note pursuant to the terms of this Note, such
new Note (i) shall be of like tenor with this Note, (ii) shall represent, as indicated on the face of such new Note, the Principal
remaining outstanding (or in the case of a new Note being issued pursuant to Section 13(a) or Section 13(c), the Principal designated
by the Holder which, when added to the principal represented by the other new Notes issued in connection with such issuance, does
not exceed the Principal remaining outstanding under this Note immediately prior to such issuance of new Notes), (iii) shall
have an issuance date, as indicated on the face of such new Note, which is the same as the Issuance Date of this Note, (iv) shall
have the same rights and conditions as this Note, and (v) shall represent accrued Interest and Late Charges on the Principal
and Interest of this Note, from the Issuance Date.

(14)          
REMEDIES, CHARACTERIZATIONS, OTHER OBLIGATIONS, BREACHES AND INJUNCTIVE RELIEF. The remedies provided in this Note
shall be cumulative and in addition to all other remedies available under this Note and any of the other Transaction Documents
at law or in equity (including a decree of specific performance and/or other injunctive relief), and nothing herein shall limit
the Holder’s right to pursue actual and consequential damages for any failure by the Company to comply with the terms of
this Note. Amounts set forth or provided for herein with respect to payments, conversion and the like (and the computation thereof)
shall be the amounts to be received by the Holder and shall not, except as expressly provided herein, be subject to any other obligation
of the Company (or the performance thereof). The Company acknowledges that a breach by it of its obligations hereunder will cause
irreparable harm to the Holder and that the remedy at law for any such breach may be inadequate. The Company therefore agrees that,
in the event of any such breach or threatened breach, the Holder shall be entitled, in addition to all other available remedies,
to an injunction restraining any breach, without the necessity of showing economic loss and without any bond or other security
being required.

(15)          
PAYMENT OF COLLECTION, ENFORCEMENT AND OTHER COSTS. If (a) this Note is placed in the hands of an attorney for collection
or enforcement or is collected or enforced through any legal proceeding or the Holder otherwise takes action to collect amounts
due under this Note or to enforce the provisions of this Note or (b) there occurs any bankruptcy, reorganization, receivership
of the Company or other proceedings affecting Company creditors’ rights and involving a claim under this Note, then the Company
shall pay the costs incurred by the Holder for such collection, enforcement or action or in connection with such bankruptcy, reorganization,
receivership or other proceeding, including, but not limited to, reasonable attorneys’ fees and disbursements.

    	 	16	 

    	 

    

(16)          
CONSTRUCTION; HEADINGS. This Note shall be deemed to be jointly drafted by the Company and the Holder of this Note
and shall not be construed against any person as the drafter hereof. The headings of this Note are for convenience of reference
and shall not form part of, or affect the interpretation of, this Note.

(17)          
FAILURE OR INDULGENCE NOT WAIVER. No failure or delay on the part of the Holder in the exercise of any power, right
or privilege hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or
privilege preclude other or further exercise thereof or of any other right, power or privilege.

(18)          
DISPUTE RESOLUTION. In the case of a dispute as to the arithmetic calculation of the Conversion Rate, the Company
shall submit the disputed arithmetic calculations via facsimile within three (3) Business Days of receipt, or deemed receipt, of
the Conversion Notice, as the case may be, to the Holder. If the Holder and the Company are unable to agree upon such calculation
within five (5) Business Days of such disputed arithmetic calculation being submitted to the Holder, then the Company shall, within
one Business Day submit via facsimile the disputed arithmetic calculation of the Conversion Rate to the Company’s independent,
outside accountant. The Company, at the Company’s expense, shall cause the accountant, as the case may be, to perform the
calculations and notify the Company and the Holder of the results no later than ten (10) Business Days from the time it receives
the disputed calculations. Such accountant’s calculation, as the case may be, shall be binding upon all parties absent demonstrable
error.

(19)          
NOTICES; PAYMENTS.

(a)              
Notices. Whenever notice is required to be given under this Note, unless otherwise provided herein, such notice shall
be given in accordance with the Purchase Agreement. The Company shall provide the Holder with prompt written notice of all actions
taken pursuant to this Note, including in reasonable detail a description of such action and the reason therefor. Without limiting
the generality of the foregoing, the Company will give written notice to the Holder of any adjustment of the Conversion Price,
setting forth in reasonable detail, and certifying, the calculation of such adjustment.

(b)              
Payments. Whenever any payment of cash is to be made by the Company to any Person pursuant to this Note, such payment
shall be made in lawful money of the United States of America by a check drawn on the account of the Company and sent via overnight
courier service to such Person at such address as previously provided to the Company in writing (which address, in the case of
each of the initial Holder of this Note, shall initially be as set forth on the signature page to the Purchase Agreement); provided
that the Holder may elect to receive a payment of cash via wire transfer of immediately available funds by providing the Company
with prior written notice setting out such request and the Holder’s wire transfer instructions. Whenever any amount expressed
to be due by the terms of this Note is due on any day which is not a Business Day, the same shall instead be due on the next succeeding
day which is a Business Day. Any amount of Principal or other amounts due under the this Note or the Transaction Documents, other
than Interest, which is not paid when due shall result in a late charge being incurred and payable by the Company in an amount
equal to interest on such amount at the rate of five percent (5%) per annum from the date such amount was due until the same is
paid in full (“Late Charge”).

    	 	17	 

    	 

    

(20)          
CANCELLATION. After all Principal, accrued Interest and other amounts at any time owed on this Note have been paid
in full, this Note shall automatically be deemed canceled, shall be surrendered to the Company for cancellation and shall not be
reissued.

(21)          
WAIVER OF NOTICE. To the extent permitted by law, the Company hereby waives demand, notice, presentment, protest
and all other demands and notices (other than the notices expressly provided for in this Note) in connection with the delivery,
acceptance, default or enforcement of this Note and the Purchase Agreement.

(22)          
GOVERNING LAW. This Note shall be construed and enforced in accordance with, and all questions concerning the construction,
validity, interpretation and performance of this Note shall be governed by, the internal laws of the State of New York, without
giving effect to any choice of law or conflict of law provision or rule (whether of the State of New York or any other jurisdictions)
that would cause the application of the laws of any jurisdictions other than the State of New York.

(23)          
CERTAIN DEFINITIONS. For purposes of this Note, the following terms shall have the following meanings:

(a)              
[Intentionally omitted.]

(b)              
“Business Day” means any day other than Saturday, Sunday or other day on which commercial banks in The
City of New York are authorized or required by law to remain closed.

(c)              
“Change of Control” means the consummation of any transaction described in clauses (i) through (v) of
the definition of “Major Event” in Section 2(d)(i).

(d)              
“Closing Sale Price” means, as of any date, the last closing trade price for the Common Stock on the
Eligible Market representing the principal securities exchange or trading market for the Common Stock, as reported by Bloomberg,
or, if such Eligible Market begins to operate on an extended hours basis and does not designate the closing trade price, then the
last trade price of such security prior to 4:00:00 p.m., New York time, as reported by Bloomberg, or, if no Eligible Market
is the principal securities exchange or trading market for the Common Stock, the last closing trade price of such security on the
principal securities exchange or trading market where such security is listed or traded as reported by Bloomberg, or if the foregoing
do not apply, the last trade price of such security in the over-the-counter market on the electronic bulletin board for such security
as reported by Bloomberg, or, if no last trade price is reported for such security by Bloomberg, the average of the ask prices
of any market makers for such security as reported in the “pink sheets” by OTC Markets Group, Inc. or any successor
thereto. If the Closing Sale Price cannot be calculated for a security on a particular date on any of the foregoing bases, the
Closing Sale Price of such security on such date shall be the fair market value as mutually determined by the Company and the Holder.

    	 	18	 

    	 

    

(e)              
“Common Stock” means the shares of the Company’s common stock, par value $0.001 per share, and
any other securities of the Company which may be issued or issuable with respect to, in exchange for, or in substitution of, such
shares of common stock (including without limitation, by way of recapitalization, reclassification, reorganization, merger or otherwise).

(f)               
“Contingent Obligation” means, as to any Person, any direct or indirect liability, contingent or otherwise,
of that Person with respect to any indebtedness, lease, dividend or other obligation of another Person if the primary purpose or
intent of the Person incurring such liability, or the primary effect thereof, is to provide assurance to the obligee of such liability
that such liability will be paid or discharged, or that any agreements relating thereto will be complied with, or that the holders
of such liability will be protected (in whole or in part) against loss with respect thereto.

(g)              
“Convertible Securities” means any stock or securities (other than Options) directly or indirectly convertible
into or exercisable or exchangeable for Common Stock.

(h)              
“Eligible Market” means The New York Stock Exchange (NYSE), the NYSE American, or The Nasdaq Stock Market,
or their successors.

(i)                
“Exchange Act” means the United States Securities Exchange Act of 1934, as amended, and the rules and
regulations thereunder.

(j)                
“GAAP” means United States generally accepted accounting principles, consistently applied, or successor
conventions.

(k)              
“Indebtedness” of any Person means, without duplication (a) all indebtedness for borrowed money, (b)
all obligations issued, undertaken or assumed as the deferred purchase price of property or services including, without limitation,
“capital leases” in accordance with GAAP (other than trade payables entered into in the ordinary course of business),
(c) all reimbursement or payment obligations with respect to letters of credit, surety bonds and other similar instruments, (d)
all obligations evidenced by notes, bonds, debentures or similar instruments, including obligations so evidenced incurred in connection
with the acquisition of property, assets or businesses, (e) all indebtedness created or arising under any conditional sale or other
title retention agreement, or incurred as financing, in either case with respect to any property or assets acquired with the proceeds
of such indebtedness (even though the rights and remedies of the seller or bank under such agreement in the event of default are
limited to repossession or sale of such property), (f) all monetary obligations under any leasing or similar arrangement which,
in connection with GAAP, consistently applied for the periods covered thereby, is classified as a capital lease, (g) any amount
raised by acceptance under any acceptance credit facility, (h) receivables sold or discounted (other than within the framework
of factoring, securitization or similar transaction where recourse is only to such receivables or proceeds), (i) any derivative
transaction, (j) any counter-indemnity obligation in respect of a guarantee, indemnity, bond, standby or documentary letter
of credit or any other instrument issued by a bank or financial institution (excluding commercial letters of credit issued in the
ordinary course of business), (k) all indebtedness referred to in clauses (a) through (j) above secured by (or for which the
holder of such Indebtedness has an existing right, contingent or otherwise, to be secured by) any mortgage, lien, pledge, charge,
security interest or other encumbrance upon or in any property or assets (including accounts and contract rights) owned by any
Person, even though the Person which owns such assets or property has not assumed or become liable for the payment of such indebtedness,
and (l) all Contingent Obligations in respect of indebtedness or obligations of others of the kinds referred to in clauses (a)
through (k) above.

    	 	19	 

    	 

    

(l)                
“Options” means any rights, warrants or options to subscribe for or purchase Common Stock or Convertible
Securities.

(m)            
“Person” means an individual, a limited liability company, a partnership, a joint venture, a corporation,
a trust, an unincorporated organization, any other entity and a government or any department or agency thereof.

(n)              
“Reclassification” means any reclassification or change of shares of Common Stock issuable upon conversion
of this Note (other than a change in par value, or from par value to no par value, or from no par value to par value, or as a result
of a subdivision or combination).

(o)              
“Rule 144” means Rule 144 promulgated under the Securities Act and any successor provision thereto.

(p)              
“SEC” means the United States Securities and Exchange Commission.

(q)              
“Securities Act” means the Securities Act of 1933, as amended.

(r)               
“Subsidiary” means with respect to any Person, any corporation, association or other business entity
of which 50% or more of the total voting power of equity entitled (without regard to the occurrence of any contingency) to vote
in the election of directors, managers or trustees or other governing body thereof is at the time owned or controlled by such Person
(regardless of whether such equity is owned directly or through one or more other Subsidiaries of such Person or a combination
thereof).

(s)               
“Successor Entity” means the Person, which may be the Company, formed by, resulting from or surviving
any Change of Control or the person with which such Change of Control transaction shall have been made. In the event that the Person
resulting from or surviving any Change of Control is a Subsidiary, Successor Entity shall be the parent of such Subsidiary.

(t)                
“Transaction Documents” has the meaning given to such term in the Purchase Agreement.

[Signature page follows]

    	 	20	 

    	 

    

IN WITNESS WHEREOF,
the Company has caused this Note to be duly executed as of the Issuance Date set out above.

 

	 	CareView Communications, Inc.
	 	By:_________________________________ 
	 	Name: Steven G. Johnson
	 	Title: President

 

 

    	 

    	 

    

 

EXHIBIT I

CAREVIEW COMMUNICATIONS, INC.

CONVERSION NOTICE

Reference is made to the Convertible
Note (the “Note”) issued to the undersigned by CareView Communications, Inc. (the “Company”).
In accordance with and pursuant to the Note, the undersigned hereby elects to convert the Conversion Amount (as defined in the
Note) of the Note indicated below into shares of Common Stock par value $0.001 per share (the “Common Stock”)
of the Company, as of the date specified below.

	Date of Conversion:	 
	Aggregate Conversion Amount to be converted:	 
	Please confirm the following information:
	Conversion Price:	 
	Number of shares of Common Stock to be issued:	 
	Please issue the Common Stock into which the Note is being converted in the following name and to the following address:
	Issue to:	 
	Facsimile Number:	 
	Authorization:	 
	By:	 
	Title:	 
	Dated:	 
	Account Number:	 
	  (if electronic book entry transfer)	 
	Transaction Code Number:	 
	  (if electronic book entry transfer)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00285-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00285-of-00352.parquet"}]]